BIOMAT Database Logo BIOMAT Database Logo

Inhibitory mechanism of trans-AMCHA (trans-4-aminomethyl-cyclohexane-carboxylic acid) in two children showing fibrinolysis. 1966

K Yamada, and K Inoue, and T Mizuguchi

UI MeSH Term Description Entries
D008297 Male Males
D011693 Purpura Purplish or brownish red discoloration, easily visible through the epidermis, caused by hemorrhage into the tissues. When the size of the discolorization is >2-3 cm it is generally called Ecchymoses (ECCHYMOSIS). Petechiae,Purpuras
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D005342 Fibrinolysis The natural enzymatic dissolution of FIBRIN. Fibrinolyses
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000741 Anemia, Aplastic A form of anemia in which the bone marrow fails to produce adequate numbers of peripheral blood elements. Anemia, Hypoplastic,Aplastic Anaemia,Aplastic Anemia,Anaemia, Aplastic,Aplastic Anaemias,Aplastic Anemias,Hypoplastic Anemia,Hypoplastic Anemias
D000933 Antifibrinolytic Agents Agents that prevent fibrinolysis or lysis of a blood clot or thrombus. Several endogenous antiplasmins are known. The drugs are used to control massive hemorrhage and in other coagulation disorders. Antifibrinolysin,Antifibrinolysins,Antifibrinolytic,Antifibrinolytic Agent,Antiplasmin,Antiplasmins,Antifibrinolytics,Plasmin Inhibitor,Plasmin Inhibitors,Agent, Antifibrinolytic,Agents, Antifibrinolytic,Inhibitor, Plasmin,Inhibitors, Plasmin

Related Publications

K Yamada, and K Inoue, and T Mizuguchi
[Antifibrinolytic and antihemorrhagic activity of trans-aminomethyl cyclohexane carboxylic acid (AMCHA). Clinical experience].
December 1972, Minerva medica,
K Yamada, and K Inoue, and T Mizuguchi
Clinical uses of trans-form of AMCHA (4-aminomethyl-cyclohexane-1-carboxylic acid) on several skin diseases.
September 1965, The Keio journal of medicine,
K Yamada, and K Inoue, and T Mizuguchi
Anti-inflammatory effect of antiplasmin agents, -aminocaproic acid and trans-4-aminomethyl-cyclohexane carboxylic acid, in rats.
October 1970, Acta medicinae Okayama,
K Yamada, and K Inoue, and T Mizuguchi
Fibrin-stabilizing factor inhibitors. I. Amides and esters of trans-4-(aminomethyl)cyclohexane carboxylic acid (tranexamic acid).
September 1970, Acta pharmaceutica Suecica,
K Yamada, and K Inoue, and T Mizuguchi
trans-4-(Aminomethyl)cyclohexane carboxylic acid (T-AMCHA), an anti-fibrinolytic agent, accelerates barrier recovery and prevents the epidermal hyperplasia induced by epidermal injury in hairless mice and humans.
July 1997, The Journal of investigative dermatology,
K Yamada, and K Inoue, and T Mizuguchi
trans-4-(Aminomethyl)cyclohexane carboxylic acid methylamide (t-AMCHA methylamide) inhibits the physical interaction between urokinase-type plasminogen activator and stratum corneum, and accelerates the recovery of barrier function.
December 2005, Journal of dermatological science,
K Yamada, and K Inoue, and T Mizuguchi
Biodegradation kinetics of trans-4-methyl-1-cyclohexane carboxylic acid.
February 2009, Biodegradation,
K Yamada, and K Inoue, and T Mizuguchi
[The effect of amino-methyl-cyclohexane-carboxylic acid (AMCHA) in activated hemostasis].
October 1969, Zentralblatt fur Gynakologie,
K Yamada, and K Inoue, and T Mizuguchi
AMINO METHYL CYCLOHEXANE CARBOXYLIC ACID (AMCHA), A NEW SYNTHETIC FIBRINOLYTIC INHIBITOR.
March 1965, British journal of haematology,
K Yamada, and K Inoue, and T Mizuguchi
Zymogen-activation kinetics. Modulatory effects of trans-4-(aminomethyl)cyclohexane-1-carboxylic acid and poly-D-lysine on plasminogen activation.
January 1985, The Biochemical journal,
Copied contents to your clipboard!